Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages

Project Information

NANOTAM

Grant agreement ID: 658592

DOI

10.3030/658592

Project closed

EC signature date 6 May 2015

Start date 20 May 2015

End date 19 May 2017

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost

€ 168 277,20

EU contribution

€ 168 277,20

Coordinated by

HUMANITAS MIRASOLE SPA
Italy

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Nanomedicine and cancer immunotherapy – targeting immunosuppressive cells

Author(s): Fernando Torres Andón, María José Alonso
Published in: Journal of Drug Targeting, Issue 23/7-8, 2015, Page(s) 656-671, ISSN 1061-186X
Publisher: Taylor & Francis
DOI: 10.3109/1061186X.2015.1073295